Advertisement
Singapore markets closed

  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     

  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • Bitcoin USD

    63,653.00
    -594.17 (-0.92%)
     

  • CMC Crypto 200

    1,326.16
    -70.37 (-5.04%)
     

  • S&P 500

    5,107.22
    +58.80 (+1.16%)
     

  • Dow

    38,282.49
    +196.69 (+0.52%)
     

  • Nasdaq

    15,949.71
    +337.95 (+2.16%)
     

  • Gold

    2,346.40
    +3.90 (+0.17%)
     

  • Crude Oil

    84.03
    +0.46 (+0.55%)
     

  • 10-Yr Bond

    4.6670
    -0.0390 (-0.83%)
     

  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     

  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     

  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Regulus: 3Q Earnings Snapshot

Regulus: 3Q Earnings Snapshot

Associated Press

SAN DIEGO (AP) _ Regulus Therapeutics Inc. (RGLS) on Thursday reported a loss of $10.3 million in its third quarter.

The San Diego-based company said it had a loss of $1.18 per share.

The biopharmaceutical company posted revenue of $18,000 in the period.

In the final minutes of trading on Thursday, the company's shares hit $1.77. A year ago, they were trading at $11.29.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGLS at https://www.zacks.com/ap/RGLS